Approvals/NMPA/Empagliflozin and Metformin Hydrochloride Sustained-release Tablets（IV）

Approved

化学药品

Empagliflozin and Metformin Hydrochloride Sustained-release Tablets（IV）

南京易亨制药有限公司🇨🇳 National Medical Products Administration

Approval Id: 8nb7BWls739
Approval Number: 国药准字H20265374
Generic Name: 恩格列净二甲双胍缓释片(Ⅳ)
Generic Name En: Empagliflozin and Metformin Hydrochloride Sustained-release Tablets（IV）
Drug Type: 化学药品
Dosage Form: 片剂
Strength: 每片含恩格列净25mg和盐酸二甲双胍1000mg
Reg Date: 2026-07-28
Company Name: 南京易亨制药有限公司
Company Address: 南京市江北新区华宝路118号
Production Company Name: 南京易亨制药有限公司
Production Company Address: 南京市江北新区华宝路118号
Company Detail Path: /organization/nan-jing-yi-heng-zhi-yao-you-xian-gong-si
Production Company Detail Path: /organization/nan-jing-yi-heng-zhi-yao-you-xian-gong-si

Approved

Agency

NMPA

Country

🇨🇳

Approval Date

Jul 28, 2026

Approval ID

8nb7BWls739

Type

化学药品